Research Compounds & Laboratory Materials
Biopharma
Login / Register
Sign inCreate an Account

Lost your password?

Wishlist
0 items $0.00
Menu
Biopharma
0 items $0.00
  • Home
  • Shop
    • Research Solutions
    • Research Compounds
    • Selective Receptor Research
    • Accessories Plus
  • Peptides
    • Blends
    • Cosmetic Peptides
    • HGH
    • Tissue-Pathway Research
    • Reproductive Signaling Research
    • Metabolic Research
    • Nootropics
    • NAD+
  • About Us
    • FAQs
    • Contact Us
    • Official Properties
  • Blog
  • Research Guides
    • SARMs Research
    • GLP-3 & Metabolic Peptides
    • Performance & Recovery Peptides
    • Peptide Stacks & Protocols
    • SARMs to Peptides
    • Cycle Support & PCT
  • BONUS

Tag Archives: peptide research

Home » Posts Tagged "peptide research"
Epithalon telomerase research evidence map illustration
10 Sep
blog

Epithalon Telomerase Research: Replication, Limits, and Open Questions

  • September 10, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

Review Epithalon telomerase research, the corrected 2025 cell study, older epithalamin human data, regulatory context, and the evidence still missing.

Continue reading

GHK-Cu 2026 evidence map showing research tiers
06 Sep
blog

GHK-Cu Evidence in 2026: What 64 Records Actually Show

  • September 6, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

A critical map of GHK-Cu evidence in 2026: the new 64-record review, microneedle delivery study, recruiting CuHeal trial, and major research gaps.

Continue reading

Tesamorelin 2026 meta-analysis evidence review illustration
03 Sep
blog

Tesamorelin Visceral Fat Research: What the 2026 Meta-Analysis Shows

  • September 3, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

A 2026 meta-analysis pooled five tesamorelin trials in adults with HIV. Review visceral and liver fat findings, glucose data, and evidence limits.

Continue reading

GHK-Cu Phase 2 CuHeal clinical trial research illustration
30 Aug
blog

GHK-Cu Phase 2 Trial: What the 2026 CuHeal Study Is Testing

  • August 30, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

The 2026 CuHeal Phase 2 trial is testing GHK-Cu gel in a paired wound model. Review its design, endpoints, prior evidence context, and key limits.

Continue reading

DSIP peptide research evidence review covering discovery, sleep studies, and unresolved biology
27 Aug
blog

DSIP Peptide Research: Sleep Evidence and Unresolved Biology

  • August 27, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

Explore DSIP peptide research, from its 1977 rabbit discovery to small human sleep studies, ACTH findings, conflicting results, and unresolved biology.

Continue reading

Thymosin Alpha-1 research illustration covering dendritic cells, TLR7, and CD8 T cells
23 Aug
blog

Thymosin Alpha-1 Research: T Cells and Cancer Immunity

  • August 23, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

Review 2026 Thymosin Alpha-1 research on dendritic-cell TLR7 signaling, CD8 T-cell activation, exhaustion markers, HCC models, and evidence limits.

Continue reading

AOD9604 research evidence review covering structure, preclinical studies, and human trials
20 Aug
blog

AOD9604 Research: HGH Fragment Biology, Trials, and Evidence

  • August 20, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

Review AOD9604 research on HGH fragment structure, fat-metabolism models, human trial history, regulatory context, and major evidence limits.

Continue reading

Selank research evidence map covering molecular, preclinical, and human studies
16 Aug
blog

Selank Research: Mechanisms, Evidence, and Study Limitations

  • August 16, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

Explore Selank research on GABAergic signalling, stress models, human pilot studies, its differences from Semax, and important evidence limitations.

Continue reading

28 Jun
Research Peptides

MOTS-c Cardiac Inflammation Research

  • July 29, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

MOTS-c cardiac inflammation research: June 2026 diabetic-model evidence, metabolic signaling limits, comparisons, and FAQ.

Continue reading

11 Jun
Research Peptides

MOTS-c Research in 2026: Pathways Update

  • July 29, 2026
  • By author-avatar BioPharma Editorial Team
  • 0 comments

MOTS-c research in 2026: mitochondrial peptide pathways, preclinical cardiac, lung, metabolic, and cellular-stress signals explained.

Continue reading

  • 1
  • 2

GET IN TOUCH

BioPharma is a Canadian catalog for research compounds, peptides, reference materials, and laboratory accessories. Clear product details, direct support, and controlled laboratory research-use boundaries.
  • info@biopharma.cc
USEFUL LINKS
  • FAQs
  • Our Shop
  • My Account
  • Refund & Returns Policy
NEWSLETTER

Catalog questions or order support? Email BioPharma.

BioPharma © 2026. All rights reserved.
payments
  • Home
  • Shop
    • Research Solutions
    • Research Compounds
    • Selective Receptor Research
    • Accessories Plus
  • Peptides
    • Blends
    • Cosmetic Peptides
    • HGH
    • Tissue-Pathway Research
    • Reproductive Signaling Research
    • Metabolic Research
    • Nootropics
    • NAD+
  • About Us
    • FAQs
    • Contact Us
    • Official Properties
  • Blog
  • Research Guides
    • SARMs Research
    • GLP-3 & Metabolic Peptides
    • Performance & Recovery Peptides
    • Peptide Stacks & Protocols
    • SARMs to Peptides
    • Cycle Support & PCT
  • BONUS
  • Login / Register
Shopping cart
Close
Shop
Wishlist
0 items Cart
My account
BP

Age Verification

BioPharma provides controlled-access research compounds and laboratory materials. You must be 21 years of age or older to enter.

Leave site For laboratory research purposes only. Not for human or veterinary use.